[Course and prognosis of glomerulonephritis].
D000208:Acute Disease; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019867:Anti-Glomerular Basement Membrane Disease / Q000209:etiology; D000936:Antigen-Antibody Complex / Q000032:analysis; D000937:Antigen-Antibody Reactions; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D003348:Cortisone / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000150:complications / Q000175:diagnosis* / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000209:etiology; D007678:Kidney Glomerulus / Q000473:pathology; D008854:Microscopy, Electron; D006435:Renal Dialysis; D014068:Tonsillectomy; D014511:Uremia / Q000209:etiology
D000900:Anti-Bacterial Agents; D000936:Antigen-Antibody Complex; D001379:Azathioprine; D003348:Cortisone
Evoluzione e prognosi delle glomerulonefriti.